Skip to main content


Fig. 1 | EJNMMI Research

Fig. 1

From: Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease

Fig. 1

DAT SPECT imaging. Normal (a) and abnormal (b) [123I]FP-CIT SPECT imaging of patients in the LEAP cohort. Patient A is a 64-year-old male. Patient B is a 63-year-old female. DAT, dopamine transporter; SPECT; single-photon emission computed tomography; LEAP, Levodopa in EArly Parkinson’s disease

Back to article page